Dover Corp vs Herbalife Nutrition Ltd — how do they compare? Dover Corp trades at $188.83 (market cap $25.45B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: Dover Corp is far larger — about 19× Herbalife Nutrition Ltd's market cap, and Dover Corp pays a 1.11% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 73 Days and Herbalife Nutrition Ltd for 43 Days on average.
| DOV | HLF | |
|---|---|---|
Market Cap | $25.45B | $1.34B |
Volume | 661,758 | 1,589,457 |
Sector | Industrials | Consumer Staples |
52-Week High | $233.31 | $19.96 |
52-Week Low | $161.16 | $7.75 |
Typical Hold Time | 73 Days | 43 Days |
Enterprise Value | $26.95B | $3.18B |
Dividend Yield | 1.11% | — |
Signals from Pluang's Aura AI — not financial advice
Dover Corporation (DOV) trades at $188.96, showing modest daily gains of 0.36%. The stock maintains strong fundamentals with consistent earnings beats and a 67.86% analyst buy rating. Recent acquisitions and product launches demonstrate growth initiatives, while technical indicators signal near-term bearish pressure with support at $186. The company's 13.48% net margin and 14.98% ROE reflect operational efficiency.
DOV presents a compelling investment case with 28% upside to the $243.20 consensus target. Strong cash flow generation and dividend consistency support shareholder returns, though technical weakness and competitive industrial markets pose near-term risks. The upcoming Q3 2026 earnings report on September 30 will be crucial for confirming growth trajectory.
HLF trades at $12.82, up 1.34% today, with a bullish technical signal from moving averages and oscillators. The company reported mixed quarterly earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026. Revenue has been stable around $5.0B annually, with a net income margin of 4.53% in 2025. Recent news includes a $250 million share repurchase program and a planned CEO transition effective October 31, 2026.
The stock appears undervalued with a P/E of 8.22 and P/S of 0.26, supported by a 53.84% analyst buy rating and a $19.00 consensus price target. Key risks include high debt levels, with total liabilities at $3.53B, and inconsistent earnings performance. Positive cash flow trends in 2026 projections and margin expansion plans offer potential upside, but investor caution is warranted due to ongoing leadership changes and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →